Authors
Loading...
Randomized trial demonstrates improved antitumor efficacy in tumor-selective prodrug nanoassemblies, suggesting a novel delivery strategy.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: